story of the week
Similar Outcomes With the CD34 Antibody–Covered Sirolimus-Eluting Combo Stent and Sirolimus-Eluting Orsiro Stent
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Clinical Comparison of the Dual Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated with Percutaneous Coronary Intervention: The SORT OUT X Trial
Circulation 2021 Apr 07;[EPub Ahead of Print], L Jakobsen, EH Christiansen, P Freeman, J Kahlert, K Veien, M Maeng, B Raungaard, J Ellert, AB Villadsen, SD Kristensen, O Ahlehoff, MK Christensen, CJ Terkelsen, HE Bøtker, J Aaroe, T Thim, L Thuesen, A Aziz, A Eftekhari, RV Jensen, NB Støttrup, JG Rasmussen, A Junker, SE Jensen, HS Hansen, LO JensenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.